Skip to main content
Top
Published in: Supportive Care in Cancer 2/2019

01-02-2019 | Original Article

Knowledge, fatigue, and cognitive factors as predictors of lymphoedema risk-reduction behaviours in women with cancer

Authors: Miyako Tsuchiya, Mariko Masujima, Tomoyasu Kato, Shun-ichi Ikeda, Chikako Shimizu, Takayuki Kinoshita, Sho Shiino, Makiko Suzuki, Miki Mori, Miyako Takahashi

Published in: Supportive Care in Cancer | Issue 2/2019

Login to get access

Abstract

Objective

To identify social–cognitive factors predicting lymphoedema risk-reduction behaviours (hereafter, self-care) after discharge among patients in Japan with breast or gynaecological cancers, using the extended model of the theory of planned behaviour.

Methods

A cross-sectional questionnaire study was conducted in an oncology hospital. Items measured were (1) knowledge about self-care; (2) the Cancer Fatigue Scale; (3) social–cognitive factors in the theory of planned behaviour (attitudes, subjective norms, and perceived behavioural control); (4) self-care (limb hygiene, observation, articular movement, recommended risk-reduction behaviours in daily life, and diet and weight control); and (5) demographics. Of 202 respondents, 147 who had not been diagnosed with lymphoedema were eligible for statistical analysis (65.3% with gynaecological cancer, 34.7% with breast cancer).

Results

Structural equation modelling was used to examine a hypothesised model based on the theory of planned behaviour. The results revealed that a longer time since surgery, higher levels of fatigue, less knowledge, higher expected efficacy of self-care, and lower perceived behavioural control directly and significantly predicted less self-care behaviour.

Conclusions

Besides education about self-care behaviour, levels of fatigue and perceived behavioural control should be taken into account to encourage female patients with cancer to perform self-care after discharge. Continuous psycho-educational programmes after discharge may help to facilitate self-care behaviours among long-term female cancer survivors.
Literature
2.
go back to reference Kitamura K, Akazawa K (2010) Nyugan jyutsugo no rinpafushu nikansuru tashisetujittaichousa. [multi-center study in lymphedema following breast surgery]. Jpn J Clin Nurs 36:889–893 Kitamura K, Akazawa K (2010) Nyugan jyutsugo no rinpafushu nikansuru tashisetujittaichousa. [multi-center study in lymphedema following breast surgery]. Jpn J Clin Nurs 36:889–893
3.
go back to reference Takakura S, Yamada K, Sasaki H, Tanaka T (2005) Fujinkagan no kofukumakurinpasetsu kakuseijyutugono rinpafushuno hatsugenritu to sono yoboshujyutuho. [the prevalence rate following retroperitoneal lymph node dissection in gynecologic cancer and its preventive methods of surgery]. Gynecologic and Obstetric Surgery 16:136–136 Takakura S, Yamada K, Sasaki H, Tanaka T (2005) Fujinkagan no kofukumakurinpasetsu kakuseijyutugono rinpafushuno hatsugenritu to sono yoboshujyutuho. [the prevalence rate following retroperitoneal lymph node dissection in gynecologic cancer and its preventive methods of surgery]. Gynecologic and Obstetric Surgery 16:136–136
4.
go back to reference DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14:500–515CrossRef DiSipio T, Rye S, Newman B, Hayes S (2013) Incidence of unilateral arm lymphoedema after breast cancer: a systematic review and meta-analysis. Lancet Oncol 14:500–515CrossRef
5.
go back to reference Ohba Y, Todo Y, Kobayashi N, Kaneuchi M, Watari H, Takeda M, Sudo S, Kudo M, Kato H, Sakuragi N (2011) Risk factors for lower-limb lymphedema after surgery for cervical cancer. Int J Clin Oncol 16:238–243CrossRef Ohba Y, Todo Y, Kobayashi N, Kaneuchi M, Watari H, Takeda M, Sudo S, Kudo M, Kato H, Sakuragi N (2011) Risk factors for lower-limb lymphedema after surgery for cervical cancer. Int J Clin Oncol 16:238–243CrossRef
6.
go back to reference The International Society of Lymphology (2016) The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology. Lymphology 49:170–184 The International Society of Lymphology (2016) The diagnosis and treatment of peripheral lymphedema: 2016 consensus document of the International Society of Lymphology. Lymphology 49:170–184
7.
go back to reference Salani R, Preston MM, Hade EM, Johns J, Fowler J, Paskett EP, Katz ML (2014) Swelling among women who need education about leg lymphedema: a descriptive study of lymphedema in women undergoing surgery for endometrial cancer. Int J Gynecol Cancer 24:1507–1512CrossRef Salani R, Preston MM, Hade EM, Johns J, Fowler J, Paskett EP, Katz ML (2014) Swelling among women who need education about leg lymphedema: a descriptive study of lymphedema in women undergoing surgery for endometrial cancer. Int J Gynecol Cancer 24:1507–1512CrossRef
8.
go back to reference Tsuchiya M, Horn S, Ingham R (2008) Arm symptoms and QoL in Japanese breast cancer patients. J Lymphoedema 3:130–135 Tsuchiya M, Horn S, Ingham R (2008) Arm symptoms and QoL in Japanese breast cancer patients. J Lymphoedema 3:130–135
9.
go back to reference Rowlands IJ, Beesley VL, Janda M, Hayes SC, Obermair A, Quinn MA et al (2014) Quality of life of women with lower limb swelling or lymphedema 3-5 years following endometrial cancer. Gynecol Oncol 133(2):314–318CrossRef Rowlands IJ, Beesley VL, Janda M, Hayes SC, Obermair A, Quinn MA et al (2014) Quality of life of women with lower limb swelling or lymphedema 3-5 years following endometrial cancer. Gynecol Oncol 133(2):314–318CrossRef
10.
go back to reference Tsuchiya M, Takahashi M (2016) Psychosocial impact of lymphedema after breast surgery. Curr Breast Cancer Rep 8:47–51CrossRef Tsuchiya M, Takahashi M (2016) Psychosocial impact of lymphedema after breast surgery. Curr Breast Cancer Rep 8:47–51CrossRef
14.
go back to reference The Japanese Lymphedema Society (2018) Clinical guideline for lymphedema. In: Kanehara & Co. Ltd, Tokyo The Japanese Lymphedema Society (2018) Clinical guideline for lymphedema. In: Kanehara & Co. Ltd, Tokyo
15.
go back to reference The Japan Association of Rehabilitation Medicine (2013) Guideline for cancer rehabilitation. Kanehara & Co., Ltd, Tokyo The Japan Association of Rehabilitation Medicine (2013) Guideline for cancer rehabilitation. Kanehara & Co., Ltd, Tokyo
16.
go back to reference Fu MR (2005) Breast cancer survivors' intentions of managing lymphedema. Cancer Nurs 28(6):446–457CrossRef Fu MR (2005) Breast cancer survivors' intentions of managing lymphedema. Cancer Nurs 28(6):446–457CrossRef
17.
go back to reference Kusaka Y, Nakamura Y, Atogami F, Yoshizawa T (2015) Gynecological cancer patients’ impression after taking the lymphedema preventive class: recognizing risk of developing lymphedema. J Jpn Soc Cancer Nurs 29:5–13 Kusaka Y, Nakamura Y, Atogami F, Yoshizawa T (2015) Gynecological cancer patients’ impression after taking the lymphedema preventive class: recognizing risk of developing lymphedema. J Jpn Soc Cancer Nurs 29:5–13
18.
go back to reference Masujima M, Sato R (2008) The perceptions and coping behaviors regarding lymphedma of patients who developed lymphedema following breast cancer surgery. Journal of Chiba Academy of Nursing Science 14:17–25 Masujima M, Sato R (2008) The perceptions and coping behaviors regarding lymphedma of patients who developed lymphedema following breast cancer surgery. Journal of Chiba Academy of Nursing Science 14:17–25
19.
go back to reference Abe A, Matsumoto K, Hirota N, Mori H, Hisamura M (2007) Rinpasetu kakuseiwo okonatta fujinkaganjyutsugokanjyaniokeru rinpafushuyobou taishohouhou jissennnojihatuseini eikyousuru youin [factors affecting motivation of lymphedema prevention and coping strategies among female organ-related cancer patients who underwent lymph node dissections]. Yamaguchi University Hospital Department of Nursing. Res Pap 82:52–55 Abe A, Matsumoto K, Hirota N, Mori H, Hisamura M (2007) Rinpasetu kakuseiwo okonatta fujinkaganjyutsugokanjyaniokeru rinpafushuyobou taishohouhou jissennnojihatuseini eikyousuru youin [factors affecting motivation of lymphedema prevention and coping strategies among female organ-related cancer patients who underwent lymph node dissections]. Yamaguchi University Hospital Department of Nursing. Res Pap 82:52–55
20.
go back to reference Nakamori M, Arao H (2016) A concept analysis: awareness of lymphedema symptoms in post-operative cancer patients with secondary lymphedema. J Jpn Soc Cancer Nurs 30:14–21 Nakamori M, Arao H (2016) A concept analysis: awareness of lymphedema symptoms in post-operative cancer patients with secondary lymphedema. J Jpn Soc Cancer Nurs 30:14–21
21.
go back to reference Sherman KA, Koelmeyer L (2013) Psychosocial predictors of adherence to lymphedema risk minimization guidelines among women with breast cancer. Psychooncology 22(5):1120–1126CrossRef Sherman KA, Koelmeyer L (2013) Psychosocial predictors of adherence to lymphedema risk minimization guidelines among women with breast cancer. Psychooncology 22(5):1120–1126CrossRef
22.
go back to reference Sherman KA, Miller SM, Roussi P, Taylor A (2015) Factors predicting adherence to risk management behaviors of women at increased risk for developing lymphedema. Support Care Cancer 23(1):61–69CrossRef Sherman KA, Miller SM, Roussi P, Taylor A (2015) Factors predicting adherence to risk management behaviors of women at increased risk for developing lymphedema. Support Care Cancer 23(1):61–69CrossRef
23.
go back to reference Ajzen I (1985) From intention to action: a theory of planned behavior. In: Kuhl J, Backman J (eds) Action control: from cognition to behaviors. Springer, New York, pp 11–39CrossRef Ajzen I (1985) From intention to action: a theory of planned behavior. In: Kuhl J, Backman J (eds) Action control: from cognition to behaviors. Springer, New York, pp 11–39CrossRef
24.
go back to reference Buffart LM, de Bree R, Altena M, van der Werff S, Drossaert CHC, Speksnijder CM, et al (2017) Demographic, clinical, lifestyle-related, and social-cognitive correlates of physical activity in head and neck cancer survivors. Support Care Cancer. https://doi.org/10.1007/s00520-017-3966-3 Buffart LM, de Bree R, Altena M, van der Werff S, Drossaert CHC, Speksnijder CM, et al (2017) Demographic, clinical, lifestyle-related, and social-cognitive correlates of physical activity in head and neck cancer survivors. Support Care Cancer. https://​doi.​org/​10.​1007/​s00520-017-3966-3
26.
go back to reference Ajzen I (1991) The theory of planned behavior. Organ Behav Hum Decis Process 50:179–211CrossRef Ajzen I (1991) The theory of planned behavior. Organ Behav Hum Decis Process 50:179–211CrossRef
27.
go back to reference Schmidt ME, Chang-Claude J, Seibold P, Vrieling A, Heinz J, Flesch-Janys D et al (2015) Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study. Psychooncology 24(1):40–46CrossRef Schmidt ME, Chang-Claude J, Seibold P, Vrieling A, Heinz J, Flesch-Janys D et al (2015) Determinants of long-term fatigue in breast cancer survivors: results of a prospective patient cohort study. Psychooncology 24(1):40–46CrossRef
28.
go back to reference Hoffman AJ, von Eye A, Gift AG, Given BA, Given CW, Rothert M (2009) Testing a theoretical model of perceived self-efficacy for cancer-related fatigue self-management and optimal physical functional status. Nurs Res 58(1):32–41CrossRef Hoffman AJ, von Eye A, Gift AG, Given BA, Given CW, Rothert M (2009) Testing a theoretical model of perceived self-efficacy for cancer-related fatigue self-management and optimal physical functional status. Nurs Res 58(1):32–41CrossRef
30.
go back to reference Okuyama T, Akechi T, Kugaya A, Okamura H, Shima Y, Maruguchi M et al (2000) Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manag 19(1):5–14CrossRef Okuyama T, Akechi T, Kugaya A, Okamura H, Shima Y, Maruguchi M et al (2000) Development and validation of the cancer fatigue scale: a brief, three-dimensional, self-rating scale for assessment of fatigue in cancer patients. J Pain Symptom Manag 19(1):5–14CrossRef
31.
go back to reference Katayama F, Kodama M, Osada H (2009) Development of the Japanese version of the Illness Perception Questionnaire: reliability and validity with hemodialysis data. The Japanese Journal of Health Psychology 22:28–39CrossRef Katayama F, Kodama M, Osada H (2009) Development of the Japanese version of the Illness Perception Questionnaire: reliability and validity with hemodialysis data. The Japanese Journal of Health Psychology 22:28–39CrossRef
32.
go back to reference Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron LD, Buick D (2002) The revised Illness Perception Questionnaire (IPQ-R). IPQ-revised. Psychol Health 17:1–16CrossRef Moss-Morris R, Weinman J, Petrie K, Horne R, Cameron LD, Buick D (2002) The revised Illness Perception Questionnaire (IPQ-R). IPQ-revised. Psychol Health 17:1–16CrossRef
33.
go back to reference Aizen I (1991) Construction a theory of planned behavior questionnaire. [homepage on the internet]. TPB Questionnaire Construction. people.umass.edu/~aizen/pdf/tpb.measurement.pdf. Accessed 2 Dec 2017 Aizen I (1991) Construction a theory of planned behavior questionnaire. [homepage on the internet]. TPB Questionnaire Construction. people.umass.edu/~aizen/pdf/tpb.measurement.pdf. Accessed 2 Dec 2017
34.
go back to reference Hu LT, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model 6:1–55CrossRef Hu LT, Bentler PM (1999) Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct Equ Model 6:1–55CrossRef
35.
go back to reference Little TD, Cunningham WA, Shahar G (2002) To parcel or not to parcel: exploring the question, weighing the merits. Struct Equ Model 9:151–173CrossRef Little TD, Cunningham WA, Shahar G (2002) To parcel or not to parcel: exploring the question, weighing the merits. Struct Equ Model 9:151–173CrossRef
36.
go back to reference Drabe N, Steinert H, Moergeli H, Weidt S, Strobel K, Jenewein J (2016) Perception of treatment burden, psychological distress, and fatigue in thyroid cancer patients and their partners—effects of gender, role, and time since diagnosis. Psychooncology 25(2):203–209CrossRef Drabe N, Steinert H, Moergeli H, Weidt S, Strobel K, Jenewein J (2016) Perception of treatment burden, psychological distress, and fatigue in thyroid cancer patients and their partners—effects of gender, role, and time since diagnosis. Psychooncology 25(2):203–209CrossRef
37.
go back to reference Honda K, Kagawa-Singer M (2006) Cognitive mediators linking social support networks to colorectal cancer screening adherence. J Behav Med 29(5):449–460CrossRef Honda K, Kagawa-Singer M (2006) Cognitive mediators linking social support networks to colorectal cancer screening adherence. J Behav Med 29(5):449–460CrossRef
39.
go back to reference Tsuchiya M, Horn S, Ingham R (2012) Information provision and problem-solving processes in Japanese breast cancer survivors with lymphoedema symptoms. Scand J Caring Sci 26(1):53–60CrossRef Tsuchiya M, Horn S, Ingham R (2012) Information provision and problem-solving processes in Japanese breast cancer survivors with lymphoedema symptoms. Scand J Caring Sci 26(1):53–60CrossRef
Metadata
Title
Knowledge, fatigue, and cognitive factors as predictors of lymphoedema risk-reduction behaviours in women with cancer
Authors
Miyako Tsuchiya
Mariko Masujima
Tomoyasu Kato
Shun-ichi Ikeda
Chikako Shimizu
Takayuki Kinoshita
Sho Shiino
Makiko Suzuki
Miki Mori
Miyako Takahashi
Publication date
01-02-2019
Publisher
Springer Berlin Heidelberg
Published in
Supportive Care in Cancer / Issue 2/2019
Print ISSN: 0941-4355
Electronic ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-018-4349-0

Other articles of this Issue 2/2019

Supportive Care in Cancer 2/2019 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine